leadf
logo-loader
viewPredictmedix Inc.
(
CSE:PMEDOTCQB:PMEDF
)

Predictmedix announces tie-up with India's premier defence technology firm to target government and public sector market

Paras Defence & Space Technologies Ltd is already a registered vendor to almost all the government and public sector departments in India

Predictmedix Inc. -
Predictmedix's technology is focused broadly on four areas - impairment, infectious disease, mental health and remote patient monitoring/telehealth

Predictmedix Inc (CSE:PMED) (OTCQB:PMEDF) has announced a tie-up with India's premier defence technology company in a bid to launch the Artificial Intelligence-focused workplace health firm's technology in the government and public sector in South Asia. 

Paras Defence & Space Technologies Ltd (PARAS) is already a registered vendor to almost all the government and public sector departments in India. 

READ: Predictmedix partners for clinical research with group led by Dr Samira Rahimi, an assistant professor at McGill University

Predictmedix will work alongside the group to launch its infectious disease symptom and impairment screening technologies within these sectors.

"We are extremely excited to partner with Paras as not only are they the premier defence technology company in India but they also have an established presence in the government and the public sector," said Dr Rahul Kushwah, chief operating officer of Predictmedix, in a statement.

"We will be leveraging their expertise not only for fabrication but also to target this significant business opportunity."

Predictmedix's technology is focused broadly on four areas - impairment, infectious disease, mental health and remote patient monitoring/telehealth. The firm has said the market opportunity across this spectrum is enormous - up to an eye-watering US$300 billion.

It has developed an innovative platform using mass-screening and artificial intelligence (AI) to collect data, which can identify if someone is under the influence of cannabis or alcohol impairment.

Amid the current COVID-19 crisis, the firm is also expanding its proprietary AI technology to screen for infectious disease symptoms.

“We are looking forward to working with Predictmedix to capitalize on this market opportunity," added Anish Mehta, director at Paras on the partnership.

Paras manufactures defence electronics and space application products. It offers defence automation and control, rugged displays, computing, sensors, missile motors, rockets, telescopes, guns, and ammunition, special-purpose machinery.

Shares added 4.65% in Toronto to stand at C$0.45 each.

---Updates for share price---

Contact the author at giles@proactiveinvestors.com

Quick facts: Predictmedix Inc.

Follow
CSE:PMED

Price: 0.32 CAD

Market Cap: $34.82 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Predictmedix to deploy Safe Entry Stations at North American tour of Hockeyfest

Predictmedix (CSE: PMED – OTCQB: PMEDF) CEO Dr Rahul Kushwah joined Steve Darling from Proactive to share news the company’s Safe Entry Station units will be deployed at the North American tour of Hockeyfest. The first HockeyFest event starts June 25, in London, Ontario and then hit 9 cities all...

on 05/20/2021

2 min read